Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - cd3
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Enhanced Antigen Reactivity of Immune Cells Expressing a Mutant Non-Signaling
CD3
Zeta Chain
Abstract: Immunotherapy is a cutting-edge new category of treatment that aims to harness and, in some cases, modify the patient’s own immune cells to improve their ability to cure diseases. It can be an effective approach for a variety of conditions, ranging from cancer to inflammatory diseases. However, a number of obstacles to the overall success...
Published: 4/8/2024
|
Inventor(s):
Paul Love
,
Guillaume Gaud
,
Christian Hinrichs
,
John Davies
Keywords(s):
CD3
,
Davies
,
Eunice Kennedy Shriver National Institute of Child Health an
,
Gaud
,
Hinrichs
,
Immuno-receptor Tyrosine-based Activation Motif
,
Immunotherapy
,
ITAM
,
Love
,
National Cancer Institute
,
Nci
,
NICHD
,
T Cell Receptor
,
TCR
,
Zeta Chain
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
,
TherapeuticArea > Oncology
,
TherapeuticArea > Immunology